Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
0.00%
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
06/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
BI-1607 + KEYTRUDA & Ipilimumab Details Cancer, Melanoma | Phase 2 Initiation | |
BI-1910 + KEYTRUDA Details Solid tumor/s, Cancer | Phase 2a Data readout | |
BI-1206 +/- rituximab & acalabrutinib Details Cancer, Solid tumor/s, Non-Hodgkin lymphoma | Phase 2a Data readout | |
BI-1808 +/- KEYTRUDA Details Advanced malignancies, Cancer | Phase 2a Data readout | |
BT-001 + KEYTRUDA Details Cancer, Solid tumor/s | Phase 1/2 Update | |
BI-1607 Details Solid tumor/s, Cancer | Phase 1 Data readout |